BlackRock Fund Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BlackRock Fund Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.6M	Buy	119,960 +9,841	+9%	+$1.03M	﹤0.01%	2449
2016 Q3	$12.2M	Buy	110,119 +8,108	+8%	+$1.07M	﹤0.01%	2348
2016 Q2	$14.9M	Buy	102,011 +46,360	+83%	+$6.57M	﹤0.01%	2192
2016 Q1	$7.97M	Buy	55,651 +4,879	+10%	+$693K	﹤0.01%	2484
2015 Q4	$7.85M	Buy	+50,772	New	+$7.41M	﹤0.01%	2587
2014 Q4	–	Sell	-48	Closed	-$7K	–	3885
2014 Q3	$7K	Sell	48 -3	-6%	-$452	﹤0.01%	3805
2014 Q2	$7K	Hold	51	–	–	﹤0.01%	3761
2014 Q1	$6K	Hold	51	–	–	﹤0.01%	3751
2013 Q4	$5K	Sell	51 -3,952	-99%	-$343K	﹤0.01%	3763
2013 Q3	$304K	Buy	4,003 +477	+14%	+$31K	﹤0.01%	3270
2013 Q2	$197K	Buy	+3,526	New	+$208K	﹤0.01%	3320

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's TARO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Taro Pharmaceutical Industries Ltd. (TARO) stake by 8.9% in Q4 2016, buying an estimated $1.03M and bringing the position to 119,960 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

BlackRock Fund Advisors first reported a position in TARO in Q2 2013 and has held it in 11 quarters since. The position peaked at $14.9M in Q2 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

BlackRock Fund Advisors held 119,960 shares of Taro Pharmaceutical Industries Ltd. worth $12.6M as of Q4 2016.
BlackRock Fund Advisors bought 9,841 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $1.03M.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2449 holding.
BlackRock Fund Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and has held it in 11 quarters since.
BlackRock Fund Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $14.9M in Q2 2016.
151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.